Retatrutide is an investigational medication that works differently
Ozempic, the diabetes franchise anchor, saw sales decline 8% year over year, though the result beat lowered expectations
A comprehensive analysis of 43,365 individuals from two US healthcare databases indicated that GLP-1 RAs do not elevate the risk of pulmonary aspiration during upper gastrointestinal endoscopy in patients with T2DM when compared to SGLT-2 inhibitors, yielding a pooled risk ratio of 0.98 (95% CI, 0.73 to 1.31) among GLP-1 RA users
Next, well discuss how these weight reduction benefits also contribute to improved glycemic control
This means that is not well studied currently, there is no reliable information on the safety and side effects of microdosing GLP-1, and there are no guidelines on how microdosing should occur
In simple terms, the longer it is there in your body, the more you will feel satiated